High Purity & Quality Standards : Our BPC-157 is lab-tested with a purity level exceeding 99%
With purchase you agree to our usage restrictions, Terms of Service, Research Use Only Policy and other provided policies/disclaimers
Originator Merck carried it through Phase 2 trials and a Phase 2b hip-fracture study but never filed for approval, so there is no FDA-approved prescription version
"Will This Actually Work or Am I Wasting My Time?" We can't promise miracles, but we can tell you that BPC-157 works at the cellular level to support your body's natural healing mechanisms
Monitoring approach: Establish clear metrics (visual field, OCT, visual acuity), measure every 3-6 months, continue peptides if stable or improving, consider break if stable 12+ months on treatment, resume immediately if decline detected during break, accept ongoing use if clearly beneficial and well-tolerated
However, this may be due to BPC 157s clinical infancy and the limited number of published clinical trial articles exploring the use of the peptide
